Bioavailability Hormones Marketing Protein 
Delveinsight
JULY 30, 2020
The global Adrenoleukodystrophy market size for the forecast period 2020-30, which was estimated to be USD 922.43 In approximately 10% of the ALD patients, only signs that occur is an insufficient amount of a protein adrenocortical, and the disease is known as Addison disease.
Delveinsight
JANUARY 7, 2021
The startup recently raised USD 87 million to propel itself in a competitive market. It also slates to commence a Phase Ib trial of its second candidate, TERN-201, a vascular adhesion protein (VAP-1) inhibitor, with top-line data anticipated in the first half of 2022. Terns raises USD 87 Million for NASH drugs.
Expert insights. Personalized for you.
52 
Let's personalize your content